Biogen-Icahn showdown goes to a vote

Biogen Idec's proxy fight nears its culmination. Shareholders meet today to vote on a slate of directors named by activist investor Carl Icahn, who has called on the board to consider splitting the biotech giant in two. Report

Suggested Articles

Mobile has become universal, accessible, and multi-generational. It’s time for life science brands to revolutionize how they’re telling their story.

Former Retrophin CEO was hoping for a SCOTUS hail mary to escape his seven-year fraud sentences Turns out the court was interest in hearing his plea.

A new investigation shines light on how Purdue pushed back on negative coverage of opioids, placed opioid-friendly experts in think tanks and more.